Dr. Umut Selamet, MD

Dr. Selamet practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Selamet's NPI, 1942488804, was assigned on February 3, 2008. Dr. Selamet holds Massachusetts license 278173.

Dr. Selamet's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Selamet's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Selamet is also affiliated with Massachusetts General Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Selamet to 3 more hospitals, 3 group practices and clinics, 2 medical groups and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Selamet practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Selamet's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Selamet's licenses on file in 2 states: Massachusetts and California.

CMS data shows 810 Medicare services from Dr. Selamet across 7 procedure codes in 2024, for 273 Medicare patients. Medicare paid $60,948 for them.

CMS counts 273 Medicare patients who saw Dr. Selamet in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 3.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Selamet's median patient age at 71, with 50% women.

In 2024, Dr. Selamet wrote 539 Medicare Part D claims for 95 patients. 95% of them were for generic drugs. CMS names the drug for 409 of them, across 15 drugs with 11 or more claims each, at $7,689 in total drug cost. In 2023, CMS named 542 claims across 15 drugs.

Dr. Selamet accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Selamet as offering telehealth.

Dmand AI links 17 papers to Dr. Selamet, published from 2016 to 2024. 2023 was the busiest year, with 5. The most frequent topics are Kidney, Acute Kidney Injury and Kidney Diseases. Dr. Selamet has published most often in Kidney Int Rep. Dr. Selamet's most frequent co-authors are Maen Abdelrahim, MD, Ala Abudayyeh, MD and Ramy Magdy Hanna, MD.

CMS Open Payments shows 1 general payment to Dr. Selamet from 1 drug or device company in 2024. Consulting fees make up the largest share, 100% of the total. Exelixis Inc. paid the most, $490.